Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Nature Communications
Kondrashova, Olga O; Topp, Monique M; Nesic, Ksenija K; Lieschke, Elizabeth E; Ho, Gwo-Yaw GY; Harrell, Maria I MI; Zapparoli, Giada V GV; Hadley, Alison A; Holian, Robert R; Boehm, Emma E; Heong, Valerie V; Sanij, Elaine E; Pearson, Richard B RB; Krais, John J JJ; Johnson, Neil N; McNally, Orla O; Ananda, Sumitra S; Alsop, Kathryn K; Hutt, Karla J KJ; Kaufmann, Scott H SH; Lin, Kevin K KK; Harding, Thomas C TC; Traficante, Nadia N; , ; deFazio, Anna A; McNeish, Iain A IA; Bowtell, David D DD; Swisher, Elizabeth M EM; Dobrovic, Alexander A; Wakefield, Matthew J MJ; Scott, Clare L CL